Risk stratification using pharmaceutical data, in combination with behavioral insights, can identify that plan member before a traditional condition-based program can. (Photo: Shutte
Self-insured employers seeking to squeeze costs out of their health plans have taken savvy steps to target specific member sub-segments for supplemental care. The rise of programs specific to cancer, diabetes and heart disease, and musculoskeletal conditions like arthritis, attests to the recognition that reducing the costs of a few high users can have faster, greater impact on both overall costs and individuals' health outcomes than addressing a broader population.
These population health efforts almost always focus on a specific condition or disease. It's a solid step, and the efforts have made an impact–but self-insured employers are leaving cost-saving and member care opportunities on the table.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
